Andreas Hadjimichael, 10% Owner at Karyopharm Therapeutics Inc. (KPTI), sold 37,648 shares at $8.03 ($302K) on 2016-06-23, disclosed to the SEC on 2016-06-27.
Open-market sale of $302k KPTI by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.03 | 18,824 | $151K | 50.0% |
| 2 | $8.03 | 18,824 | $151K | 50.0% |
| Total | $8.03 avg | 37,648 | $302K | 100% |
| Filing → |
| KPTI | SELL | 2018-07-23 | $4.8M | — | Filing → |
| KPTI | SELL | 2016-05-23 | $298K | — | Filing → |
| KPTI | SELL | 2016-05-12 | $362K | — | Filing → |